This Edition
ARTICLE | Clinical News
PC-DAC: Exendin-4: Phase I/II start
WIR Staff
August 29, 2005 7:00 AM UTC
CJC will start in 1Q06 a single-dose, dose-escalation Phase I/II trial in 33-55 patients. ...